Stocks Hitting 52-Week Lows

shares reached a new 52-week low of $31.21 after dropping 3.43 percent on Friday.

shares fell 77.83 percent to reach a new 52-week low of $3.92 after the company reported that topline results of its VTI-208 trial failed to meet the primary endpoint for overall survival. Credit Suisse downgraded Vital Therapies from Outperform to Neutral and lowered the price target from $25.00 to $9.00.

shares touched a new 52-week low of $22.191. Yelp shares have dropped 72.05 percent over the past 52 weeks, while the S&P 500 index has declined 1.35 percent in the same period.

shares touched a new 52-week low of $210.54. Baird downgraded W W Grainger from Outperform to Neutral and lowered the target price from $258 to $240.